Synthesis of non-cytotoxic poly(ester-amine) dendrimers as potential solubility enhancers for drugs: Methotrexate as a case study

Molecules

Volumn 15, Issue 11, 2010, Pages 8082-8097

  Soto Castro, Delia ^a   Cruz Morales, Jorge A ^a   Apan, María Teresa Ramírez ^a   Guadarrama, Patricia ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Methotrexate; Non cytotoxic dendrimers; Solubility enhancer

Indexed keywords

DENDRIMER; DRUG CARRIER; METHOTREXATE; POLY(CAPROLACTONE BLOCK ETHYLENEIMINE); POLY(CAPROLACTONE-BLOCK-ETHYLENEIMINE); POLYAMINE; POLYESTER;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SOLUBILITY; SYNTHESIS;

DENDRIMERS; DRUG CARRIERS; MAGNETIC RESONANCE SPECTROSCOPY; METHOTREXATE; MOLECULAR STRUCTURE; POLYAMINES; POLYESTERS; SOLUBILITY;

EID: 78649457350     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules15118082     Document Type: Article

References (30)

1. Astruc, D.; Chardac, F. Dendritic catalysts and dendrimers in catalysis. Chem. Rev. 2001, 101, 2991-3031.
2. Segura, J.L.; Giacalone, F.; Gómez, R.; Martín, N.; Guldi, D.M.; Luo, C.; Swartz, A.; Riedel, I.; Chirvase, D.; Parisi, J.; Dyakonov, V.; Sariciftci, N.S.; Padinger, F. Design, synthesis and photovoltaic properties of [60]fullerene based molecular materials. Mater. Sci. Eng. C 2005, 25, 835-842.
3. Ramos, E.; Guadarrama, P.; Terán, G.; Fomine, S. Push-pull hyperbranched molecules. A theoretical study. J. Phys. Org. Chem. 2009, 22, 9-16.
4. Stiriba, S.E.; Frey, H.; Haag, R. Dendritic polymers in biomedical applications: from potential to clinical use in diagnostics and therapy. Angew. Chem. Int. Ed. 2002, 41, 1329-1334.
5. Lee, C.C.; MacKay, J.A.; Fréchet, J.M.J.; Szoka, F.C. Designing dendrimers for biological applications. Nature Biotech. 2005, 23, 1517-1526.
6. Halkes, S.B.A.; Vrasidas, I.; Rooijer, G.R.; Van den Berg, A.J.J.; Liskamp, R.M.J.; Pieters, R.J. Synthesis and biological activity of polygalloyl-dendrimers as stable tannic acid mimics. Bioorg. Med. Chem. Lett. 2002, 12, 1567-1570.
7. Aulenta, F.; Hayes, W.; Rannard, S. Dendrimers: a new class of nanoscopic containers and delivery devices. Eur. Polym. J. 2003, 39, 1741-1771.
8. Boas, U.; Heegaard.P.M.H. Dendrimers in drug research. Chem. Soc. Rev. 2004, 33, 43-63.
9. Esfand, R.; Tomalia, D.A. Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications. Drug Discov. Today 2001, 6, 427-436.
10. Tomalia, D.A.; Baker, H.; Dewald, J.; Hal, M.; Kallos, G.; Martin, S. A New Class of Polymers: Starburst-Dendritic Macromolecules. Polym. J. (Tokyo) 1985, 17, 117-132.
11. Bertino, J.R.; Cronstein, B.N. Methotrexate (Milestones in Drug Therapy); Birkhäuser Verlag AG: Basel, Switzerland, 2000.
12. Fernandez, L.; Calderón, M.; Martinelli, M.; Strumia, M.; Cerecetto, H.; González, M.; Silber, J.J.; Santo, M.J. Evaluation of a new dendrimeric structure as prospective drugs carrier for intravenous administration of antichagasic active compounds. Phys. Org. Chem. 2008, 21, 1079-1085.
13. Morgan, M.T.; Carnahan, M.A.; Immoos, C.E.; Ribeiro, A.A.; Finkelstein, S.; Lee, S.J.; Grinstaff, M.W. Dendritic molecular capsules for hydrophobic compounds. J. Am. Chem. Soc. 2003, 125, 15485-15489.
14. Padilla De Jesús, O.L.; Ihre, H.R.; Gagne, L.; Fréchet, J.M.; Szoka Jr, F.C. Polyester dendritic systems for drug delivery applications: In vitro and in vivo evaluation. Bioconjugate Chem. 2002, 13, 453-461.
15. 125i-labelled polyamidoamine dendrimers in vivo. J. Control. Rel. 2000, 65, 133-148.
16. Fuchs, S.; Kapp, T.; Otto, H.; Schoneberg, T.; Franke, P.; Gust, R.; Schluter, A.D. A set of surface-modified dendrimers with potential application as drug delivery vehicles: Synthesis, in vitro cytotoxicity, and intracellular localization. Chem. Eur. J. 2004, 10, 1167-1192.
17. Krishna, T.R.; Jain, S.; Tatu, U.S.; Jayaraman, N. Synthesis of water soluble and non-toxic poly(ether imine) dendrimers. Tetrahedron 2005, 61, 4281-4288.
18. Griffin, C.; Sharda, N.; Sood, D.; Nair, J.; McNulty, J.; Pandey, S. Selective cytotoxicity of pancratistatin-related natural Amaryllidaceae alkaloids: Evaluation of the activity of two new compounds. Canc. Cell Int. 2007, 7:10.
19. Kainthan, R.K.; Hester, S.R.; Levin, E.; Devine, D.V.; Brooks, D.E. In vitro Biological Evaluation of High Molecular Weight Hyperbranched Polyglycerols. Biomaterials 2007, 28, 4581-4590.
20. Kainthan, R.K.; Brooks, D.E. In vivo biological evaluation of high molecular weight hyperbranched polyglycerols. Biomaterials 2007, 28, 4779-4787
21. Barkin, R.L. Acetaminophen, aspirin, or ibuprofen in combination analgesic products. Am. J. Ther. 2001, 8, 433-442.
22. Saha, P.; Kim, K.J.; Yamahara, H.; Crandall, E.D.; Lee, V.H.L. Influence of lipophilicity on betablocker permeation across rat alveolar epithelial cell monolayers. J. Control. Release 1994, 32, 191-200. (Pubitemid 24355180)
23. Alvarez-Figueroa, M.J.; Delgado-Charro, M.B.; Blanco-Méndez, J. Passive and iontophoretic transdermal penetration of methotrexate. Int. J. Pharm. 2001, 212, 101-107.
24. Chang, G.; Guida, W.C.; Still, W.C. An internal coordinate monte carlo method for searching conformational space. J. Am. Chem. Soc. 1989, 111, 4379-4386.
25. Saunders, M.; Houk, K.N.; Wu, Y.D.; Still, W.C.; Lipton, M.; Chang, G.; Guida, W.C. Conformations of cycloheptadecane. a comparison of methods for conformational searching. J. Am. Chem. Soc. 1990, 112, 1419-1427.
26. Goodford, P. A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. J. Med. Chem. 1985, 28, 849-857.
27. Jorgensen, W.L.; Maxwell, D.S.; Tirado-Rives, J. Development and testing of the opls all-atom force field on conformational energetics and properties of organic liquid. J. Am. Chem. Soc. 1996, 118, 11225-11236.
28. Kolossvary, I.; Guida, W.C. Low Mode Search. An efficient, automated computational method for conformational analisys: Application to cyclic and acyclic alkanes and cyclic peptides. J. Am. Chem. Soc. 1996, 118, 5011-5019.
29. Maestro, version 6.5.007; Schrödinger Inc.: New York, NY, USA, 2004.
30. Monks, A.; Scudiero, D.; Skehan, P.; Shoemaker, R.; Paul, K.; Vistica, D.; Hose, C.; Langley, J.; Cronise, P.; Vaigro-Wolff, A.; Gray-Goodrich, M.; Campbell, H.; Mayo, J.; Boyd, M. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. JNCI 1991, 83, 757-766.